Sotera Health Company (SHC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting opened with a welcome and reminder about forward-looking statements and associated risks and uncertainties.
Board members and key participants, including the independent auditor, were introduced.
Agenda and meeting materials were made available to participants, and the three main proposals were outlined: election of directors, advisory vote on executive compensation, and ratification of the auditor.
Board and executive committee updates
Recognition was given to outgoing board members for their service.
Board composition highlighted diverse expertise in management, finance, strategy, and healthcare.
Shareholder proposals
Three proposals presented: election of four directors for a three-year term, advisory approval of executive compensation, and ratification of Ernst & Young LLP as auditor for 2026.
No additional nominations were received; nominations were closed per bylaws.
Latest events from Sotera Health Company
- CEO transition, regulatory investments, and global expansion drive growth and resilience.SHC
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Leadership transition, steady growth, and robust supply chain investments drive positive outlook.SHC
Jefferies Global Healthcare Conference 20263 Jun 2026 - Strong demand, margin recovery, and new leadership drive positive outlook for the year.SHC
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - Q1 2026 delivered 10% revenue growth, margin expansion, and reaffirmed a strong 2026 outlook.SHC
Q1 20265 May 2026 - Leadership transition appoints Shader as CEO and Petras as Executive Chairman, ensuring continuity.SHC
Proxy filing5 May 2026 - 2025 delivered record revenue and margin growth; 2026 guidance projects further gains.SHC
Q4 202513 Apr 2026 - Vote on four directors, executive pay, and auditor ratification at the May 21, 2026 meeting.SHC
Proxy filing8 Apr 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and governance updates.SHC
Proxy filing8 Apr 2026 - 2026 guidance targets 5%-6.5% growth, with strong momentum and disciplined capital allocation.SHC
2026 KeyBanc Capital Markets Healthcare Forum20 Mar 2026